- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
According to our latest study, the global Autologous Biologics market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Autologous Biologics market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Autologous Biologics market size and forecasts, in consumption value ($ Million), sales quantity (Kg), and average selling prices (US$/Kg), 2018-2029
Global Autologous Biologics market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Kg), and average selling prices (US$/Kg), 2018-2029
Global Autologous Biologics market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Kg), and average selling prices (US$/Kg), 2018-2029
Global Autologous Biologics market shares of main players, shipments in revenue ($ Million), sales quantity (Kg), and ASP (US$/Kg), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Autologous Biologics
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Autologous Biologics market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Vericel Corporation, BioTime, Inc., Pharmicell Co., BrainStorm Cell Therapeutics and Opexa Therapeutics, Inc, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Autologous Biologics market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Adipose Tissue
Plasma
Others
Market segment by Application
Hospitals
Ambulatory Centers
Research Centers
Major players covered
Vericel Corporation
BioTime, Inc.
Pharmicell Co.
BrainStorm Cell Therapeutics
Opexa Therapeutics, Inc
Pharmicell Co., Inc
Neostem
Dendreon Corporation
Regenexx
Cytori Therapeutics
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Autologous Biologics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Autologous Biologics, with price, sales, revenue and global market share of Autologous Biologics from 2018 to 2023.
Chapter 3, the Autologous Biologics competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Autologous Biologics breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Autologous Biologics market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Autologous Biologics.
Chapter 14 and 15, to describe Autologous Biologics sales channel, distributors, customers, research findings and conclusion.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Autologous Biologics
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Autologous Biologics Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Adipose Tissue
1.3.3 Plasma
1.3.4 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Autologous Biologics Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospitals
1.4.3 Ambulatory Centers
1.4.4 Research Centers
1.5 Global Autologous Biologics Market Size & Forecast
1.5.1 Global Autologous Biologics Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Autologous Biologics Sales Quantity (2018-2029)
1.5.3 Global Autologous Biologics Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Vericel Corporation
2.1.1 Vericel Corporation Details
2.1.2 Vericel Corporation Major Business
2.1.3 Vericel Corporation Autologous Biologics Product and Services
2.1.4 Vericel Corporation Autologous Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Vericel Corporation Recent Developments/Updates
2.2 BioTime, Inc.
2.2.1 BioTime, Inc. Details
2.2.2 BioTime, Inc. Major Business
2.2.3 BioTime, Inc. Autologous Biologics Product and Services
2.2.4 BioTime, Inc. Autologous Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 BioTime, Inc. Recent Developments/Updates
2.3 Pharmicell Co.
2.3.1 Pharmicell Co. Details
2.3.2 Pharmicell Co. Major Business
2.3.3 Pharmicell Co. Autologous Biologics Product and Services
2.3.4 Pharmicell Co. Autologous Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Pharmicell Co. Recent Developments/Updates
2.4 BrainStorm Cell Therapeutics
2.4.1 BrainStorm Cell Therapeutics Details
2.4.2 BrainStorm Cell Therapeutics Major Business
2.4.3 BrainStorm Cell Therapeutics Autologous Biologics Product and Services
2.4.4 BrainStorm Cell Therapeutics Autologous Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 BrainStorm Cell Therapeutics Recent Developments/Updates
2.5 Opexa Therapeutics, Inc
2.5.1 Opexa Therapeutics, Inc Details
2.5.2 Opexa Therapeutics, Inc Major Business
2.5.3 Opexa Therapeutics, Inc Autologous Biologics Product and Services
2.5.4 Opexa Therapeutics, Inc Autologous Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Opexa Therapeutics, Inc Recent Developments/Updates
2.6 Pharmicell Co., Inc
2.6.1 Pharmicell Co., Inc Details
2.6.2 Pharmicell Co., Inc Major Business
2.6.3 Pharmicell Co., Inc Autologous Biologics Product and Services
2.6.4 Pharmicell Co., Inc Autologous Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Pharmicell Co., Inc Recent Developments/Updates
2.7 Neostem
2.7.1 Neostem Details
2.7.2 Neostem Major Business
2.7.3 Neostem Autologous Biologics Product and Services
2.7.4 Neostem Autologous Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Neostem Recent Developments/Updates
2.8 Dendreon Corporation
2.8.1 Dendreon Corporation Details
2.8.2 Dendreon Corporation Major Business
2.8.3 Dendreon Corporation Autologous Biologics Product and Services
2.8.4 Dendreon Corporation Autologous Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Dendreon Corporation Recent Developments/Updates
2.9 Regenexx
2.9.1 Regenexx Details
2.9.2 Regenexx Major Business
2.9.3 Regenexx Autologous Biologics Product and Services
2.9.4 Regenexx Autologous Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Regenexx Recent Developments/Updates
2.10 Cytori Therapeutics
2.10.1 Cytori Therapeutics Details
2.10.2 Cytori Therapeutics Major Business
2.10.3 Cytori Therapeutics Autologous Biologics Product and Services
2.10.4 Cytori Therapeutics Autologous Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Cytori Therapeutics Recent Developments/Updates
3 Competitive Environment: Autologous Biologics by Manufacturer
3.1 Global Autologous Biologics Sales Quantity by Manufacturer (2018-2023)
3.2 Global Autologous Biologics Revenue by Manufacturer (2018-2023)
3.3 Global Autologous Biologics Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Autologous Biologics by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Autologous Biologics Manufacturer Market Share in 2022
3.4.2 Top 6 Autologous Biologics Manufacturer Market Share in 2022
3.5 Autologous Biologics Market: Overall Company Footprint Analysis
3.5.1 Autologous Biologics Market: Region Footprint
3.5.2 Autologous Biologics Market: Company Product Type Footprint
3.5.3 Autologous Biologics Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Autologous Biologics Market Size by Region
4.1.1 Global Autologous Biologics Sales Quantity by Region (2018-2029)
4.1.2 Global Autologous Biologics Consumption Value by Region (2018-2029)
4.1.3 Global Autologous Biologics Average Price by Region (2018-2029)
4.2 North America Autologous Biologics Consumption Value (2018-2029)
4.3 Europe Autologous Biologics Consumption Value (2018-2029)
4.4 Asia-Pacific Autologous Biologics Consumption Value (2018-2029)
4.5 South America Autologous Biologics Consumption Value (2018-2029)
4.6 Middle East and Africa Autologous Biologics Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Autologous Biologics Sales Quantity by Type (2018-2029)
5.2 Global Autologous Biologics Consumption Value by Type (2018-2029)
5.3 Global Autologous Biologics Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Autologous Biologics Sales Quantity by Application (2018-2029)
6.2 Global Autologous Biologics Consumption Value by Application (2018-2029)
6.3 Global Autologous Biologics Average Price by Application (2018-2029)
7 North America
7.1 North America Autologous Biologics Sales Quantity by Type (2018-2029)
7.2 North America Autologous Biologics Sales Quantity by Application (2018-2029)
7.3 North America Autologous Biologics Market Size by Country
7.3.1 North America Autologous Biologics Sales Quantity by Country (2018-2029)
7.3.2 North America Autologous Biologics Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Autologous Biologics Sales Quantity by Type (2018-2029)
8.2 Europe Autologous Biologics Sales Quantity by Application (2018-2029)
8.3 Europe Autologous Biologics Market Size by Country
8.3.1 Europe Autologous Biologics Sales Quantity by Country (2018-2029)
8.3.2 Europe Autologous Biologics Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Autologous Biologics Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Autologous Biologics Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Autologous Biologics Market Size by Region
9.3.1 Asia-Pacific Autologous Biologics Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Autologous Biologics Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Autologous Biologics Sales Quantity by Type (2018-2029)
10.2 South America Autologous Biologics Sales Quantity by Application (2018-2029)
10.3 South America Autologous Biologics Market Size by Country
10.3.1 South America Autologous Biologics Sales Quantity by Country (2018-2029)
10.3.2 South America Autologous Biologics Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Autologous Biologics Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Autologous Biologics Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Autologous Biologics Market Size by Country
11.3.1 Middle East & Africa Autologous Biologics Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Autologous Biologics Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Autologous Biologics Market Drivers
12.2 Autologous Biologics Market Restraints
12.3 Autologous Biologics Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Autologous Biologics and Key Manufacturers
13.2 Manufacturing Costs Percentage of Autologous Biologics
13.3 Autologous Biologics Production Process
13.4 Autologous Biologics Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Autologous Biologics Typical Distributors
14.3 Autologous Biologics Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
List of Tables
Table 1. Global Autologous Biologics Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Autologous Biologics Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Vericel Corporation Basic Information, Manufacturing Base and Competitors
Table 4. Vericel Corporation Major Business
Table 5. Vericel Corporation Autologous Biologics Product and Services
Table 6. Vericel Corporation Autologous Biologics Sales Quantity (Kg), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Vericel Corporation Recent Developments/Updates
Table 8. BioTime, Inc. Basic Information, Manufacturing Base and Competitors
Table 9. BioTime, Inc. Major Business
Table 10. BioTime, Inc. Autologous Biologics Product and Services
Table 11. BioTime, Inc. Autologous Biologics Sales Quantity (Kg), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. BioTime, Inc. Recent Developments/Updates
Table 13. Pharmicell Co. Basic Information, Manufacturing Base and Competitors
Table 14. Pharmicell Co. Major Business
Table 15. Pharmicell Co. Autologous Biologics Product and Services
Table 16. Pharmicell Co. Autologous Biologics Sales Quantity (Kg), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Pharmicell Co. Recent Developments/Updates
Table 18. BrainStorm Cell Therapeutics Basic Information, Manufacturing Base and Competitors
Table 19. BrainStorm Cell Therapeutics Major Business
Table 20. BrainStorm Cell Therapeutics Autologous Biologics Product and Services
Table 21. BrainStorm Cell Therapeutics Autologous Biologics Sales Quantity (Kg), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. BrainStorm Cell Therapeutics Recent Developments/Updates
Table 23. Opexa Therapeutics, Inc Basic Information, Manufacturing Base and Competitors
Table 24. Opexa Therapeutics, Inc Major Business
Table 25. Opexa Therapeutics, Inc Autologous Biologics Product and Services
Table 26. Opexa Therapeutics, Inc Autologous Biologics Sales Quantity (Kg), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Opexa Therapeutics, Inc Recent Developments/Updates
Table 28. Pharmicell Co., Inc Basic Information, Manufacturing Base and Competitors
Table 29. Pharmicell Co., Inc Major Business
Table 30. Pharmicell Co., Inc Autologous Biologics Product and Services
Table 31. Pharmicell Co., Inc Autologous Biologics Sales Quantity (Kg), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Pharmicell Co., Inc Recent Developments/Updates
Table 33. Neostem Basic Information, Manufacturing Base and Competitors
Table 34. Neostem Major Business
Table 35. Neostem Autologous Biologics Product and Services
Table 36. Neostem Autologous Biologics Sales Quantity (Kg), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Neostem Recent Developments/Updates
Table 38. Dendreon Corporation Basic Information, Manufacturing Base and Competitors
Table 39. Dendreon Corporation Major Business
Table 40. Dendreon Corporation Autologous Biologics Product and Services
Table 41. Dendreon Corporation Autologous Biologics Sales Quantity (Kg), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Dendreon Corporation Recent Developments/Updates
Table 43. Regenexx Basic Information, Manufacturing Base and Competitors
Table 44. Regenexx Major Business
Table 45. Regenexx Autologous Biologics Product and Services
Table 46. Regenexx Autologous Biologics Sales Quantity (Kg), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Regenexx Recent Developments/Updates
Table 48. Cytori Therapeutics Basic Information, Manufacturing Base and Competitors
Table 49. Cytori Therapeutics Major Business
Table 50. Cytori Therapeutics Autologous Biologics Product and Services
Table 51. Cytori Therapeutics Autologous Biologics Sales Quantity (Kg), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Cytori Therapeutics Recent Developments/Updates
Table 53. Global Autologous Biologics Sales Quantity by Manufacturer (2018-2023) & (Kg)
Table 54. Global Autologous Biologics Revenue by Manufacturer (2018-2023) & (USD Million)
Table 55. Global Autologous Biologics Average Price by Manufacturer (2018-2023) & (US$/Kg)
Table 56. Market Position of Manufacturers in Autologous Biologics, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 57. Head Office and Autologous Biologics Production Site of Key Manufacturer
Table 58. Autologous Biologics Market: Company Product Type Footprint
Table 59. Autologous Biologics Market: Company Product Application Footprint
Table 60. Autologous Biologics New Market Entrants and Barriers to Market Entry
Table 61. Autologous Biologics Mergers, Acquisition, Agreements, and Collaborations
Table 62. Global Autologous Biologics Sales Quantity by Region (2018-2023) & (Kg)
Table 63. Global Autologous Biologics Sales Quantity by Region (2024-2029) & (Kg)
Table 64. Global Autologous Biologics Consumption Value by Region (2018-2023) & (USD Million)
Table 65. Global Autologous Biologics Consumption Value by Region (2024-2029) & (USD Million)
Table 66. Global Autologous Biologics Average Price by Region (2018-2023) & (US$/Kg)
Table 67. Global Autologous Biologics Average Price by Region (2024-2029) & (US$/Kg)
Table 68. Global Autologous Biologics Sales Quantity by Type (2018-2023) & (Kg)
Table 69. Global Autologous Biologics Sales Quantity by Type (2024-2029) & (Kg)
Table 70. Global Autologous Biologics Consumption Value by Type (2018-2023) & (USD Million)
Table 71. Global Autologous Biologics Consumption Value by Type (2024-2029) & (USD Million)
Table 72. Global Autologous Biologics Average Price by Type (2018-2023) & (US$/Kg)
Table 73. Global Autologous Biologics Average Price by Type (2024-2029) & (US$/Kg)
Table 74. Global Autologous Biologics Sales Quantity by Application (2018-2023) & (Kg)
Table 75. Global Autologous Biologics Sales Quantity by Application (2024-2029) & (Kg)
Table 76. Global Autologous Biologics Consumption Value by Application (2018-2023) & (USD Million)
Table 77. Global Autologous Biologics Consumption Value by Application (2024-2029) & (USD Million)
Table 78. Global Autologous Biologics Average Price by Application (2018-2023) & (US$/Kg)
Table 79. Global Autologous Biologics Average Price by Application (2024-2029) & (US$/Kg)
Table 80. North America Autologous Biologics Sales Quantity by Type (2018-2023) & (Kg)
Table 81. North America Autologous Biologics Sales Quantity by Type (2024-2029) & (Kg)
Table 82. North America Autologous Biologics Sales Quantity by Application (2018-2023) & (Kg)
Table 83. North America Autologous Biologics Sales Quantity by Application (2024-2029) & (Kg)
Table 84. North America Autologous Biologics Sales Quantity by Country (2018-2023) & (Kg)
Table 85. North America Autologous Biologics Sales Quantity by Country (2024-2029) & (Kg)
Table 86. North America Autologous Biologics Consumption Value by Country (2018-2023) & (USD Million)
Table 87. North America Autologous Biologics Consumption Value by Country (2024-2029) & (USD Million)
Table 88. Europe Autologous Biologics Sales Quantity by Type (2018-2023) & (Kg)
Table 89. Europe Autologous Biologics Sales Quantity by Type (2024-2029) & (Kg)
Table 90. Europe Autologous Biologics Sales Quantity by Application (2018-2023) & (Kg)
Table 91. Europe Autologous Biologics Sales Quantity by Application (2024-2029) & (Kg)
Table 92. Europe Autologous Biologics Sales Quantity by Country (2018-2023) & (Kg)
Table 93. Europe Autologous Biologics Sales Quantity by Country (2024-2029) & (Kg)
Table 94. Europe Autologous Biologics Consumption Value by Country (2018-2023) & (USD Million)
Table 95. Europe Autologous Biologics Consumption Value by Country (2024-2029) & (USD Million)
Table 96. Asia-Pacific Autologous Biologics Sales Quantity by Type (2018-2023) & (Kg)
Table 97. Asia-Pacific Autologous Biologics Sales Quantity by Type (2024-2029) & (Kg)
Table 98. Asia-Pacific Autologous Biologics Sales Quantity by Application (2018-2023) & (Kg)
Table 99. Asia-Pacific Autologous Biologics Sales Quantity by Application (2024-2029) & (Kg)
Table 100. Asia-Pacific Autologous Biologics Sales Quantity by Region (2018-2023) & (Kg)
Table 101. Asia-Pacific Autologous Biologics Sales Quantity by Region (2024-2029) & (Kg)
Table 102. Asia-Pacific Autologous Biologics Consumption Value by Region (2018-2023) & (USD Million)
Table 103. Asia-Pacific Autologous Biologics Consumption Value by Region (2024-2029) & (USD Million)
Table 104. South America Autologous Biologics Sales Quantity by Type (2018-2023) & (Kg)
Table 105. South America Autologous Biologics Sales Quantity by Type (2024-2029) & (Kg)
Table 106. South America Autologous Biologics Sales Quantity by Application (2018-2023) & (Kg)
Table 107. South America Autologous Biologics Sales Quantity by Application (2024-2029) & (Kg)
Table 108. South America Autologous Biologics Sales Quantity by Country (2018-2023) & (Kg)
Table 109. South America Autologous Biologics Sales Quantity by Country (2024-2029) & (Kg)
Table 110. South America Autologous Biologics Consumption Value by Country (2018-2023) & (USD Million)
Table 111. South America Autologous Biologics Consumption Value by Country (2024-2029) & (USD Million)
Table 112. Middle East & Africa Autologous Biologics Sales Quantity by Type (2018-2023) & (Kg)
Table 113. Middle East & Africa Autologous Biologics Sales Quantity by Type (2024-2029) & (Kg)
Table 114. Middle East & Africa Autologous Biologics Sales Quantity by Application (2018-2023) & (Kg)
Table 115. Middle East & Africa Autologous Biologics Sales Quantity by Application (2024-2029) & (Kg)
Table 116. Middle East & Africa Autologous Biologics Sales Quantity by Region (2018-2023) & (Kg)
Table 117. Middle East & Africa Autologous Biologics Sales Quantity by Region (2024-2029) & (Kg)
Table 118. Middle East & Africa Autologous Biologics Consumption Value by Region (2018-2023) & (USD Million)
Table 119. Middle East & Africa Autologous Biologics Consumption Value by Region (2024-2029) & (USD Million)
Table 120. Autologous Biologics Raw Material
Table 121. Key Manufacturers of Autologous Biologics Raw Materials
Table 122. Autologous Biologics Typical Distributors
Table 123. Autologous Biologics Typical Customers
List of Figures
Figure 1. Autologous Biologics Picture
Figure 2. Global Autologous Biologics Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Autologous Biologics Consumption Value Market Share by Type in 2022
Figure 4. Adipose Tissue Examples
Figure 5. Plasma Examples
Figure 6. Others Examples
Figure 7. Global Autologous Biologics Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 8. Global Autologous Biologics Consumption Value Market Share by Application in 2022
Figure 9. Hospitals Examples
Figure 10. Ambulatory Centers Examples
Figure 11. Research Centers Examples
Figure 12. Global Autologous Biologics Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 13. Global Autologous Biologics Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 14. Global Autologous Biologics Sales Quantity (2018-2029) & (Kg)
Figure 15. Global Autologous Biologics Average Price (2018-2029) & (US$/Kg)
Figure 16. Global Autologous Biologics Sales Quantity Market Share by Manufacturer in 2022
Figure 17. Global Autologous Biologics Consumption Value Market Share by Manufacturer in 2022
Figure 18. Producer Shipments of Autologous Biologics by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 19. Top 3 Autologous Biologics Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Top 6 Autologous Biologics Manufacturer (Consumption Value) Market Share in 2022
Figure 21. Global Autologous Biologics Sales Quantity Market Share by Region (2018-2029)
Figure 22. Global Autologous Biologics Consumption Value Market Share by Region (2018-2029)
Figure 23. North America Autologous Biologics Consumption Value (2018-2029) & (USD Million)
Figure 24. Europe Autologous Biologics Consumption Value (2018-2029) & (USD Million)
Figure 25. Asia-Pacific Autologous Biologics Consumption Value (2018-2029) & (USD Million)
Figure 26. South America Autologous Biologics Consumption Value (2018-2029) & (USD Million)
Figure 27. Middle East & Africa Autologous Biologics Consumption Value (2018-2029) & (USD Million)
Figure 28. Global Autologous Biologics Sales Quantity Market Share by Type (2018-2029)
Figure 29. Global Autologous Biologics Consumption Value Market Share by Type (2018-2029)
Figure 30. Global Autologous Biologics Average Price by Type (2018-2029) & (US$/Kg)
Figure 31. Global Autologous Biologics Sales Quantity Market Share by Application (2018-2029)
Figure 32. Global Autologous Biologics Consumption Value Market Share by Application (2018-2029)
Figure 33. Global Autologous Biologics Average Price by Application (2018-2029) & (US$/Kg)
Figure 34. North America Autologous Biologics Sales Quantity Market Share by Type (2018-2029)
Figure 35. North America Autologous Biologics Sales Quantity Market Share by Application (2018-2029)
Figure 36. North America Autologous Biologics Sales Quantity Market Share by Country (2018-2029)
Figure 37. North America Autologous Biologics Consumption Value Market Share by Country (2018-2029)
Figure 38. United States Autologous Biologics Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Canada Autologous Biologics Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Mexico Autologous Biologics Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Europe Autologous Biologics Sales Quantity Market Share by Type (2018-2029)
Figure 42. Europe Autologous Biologics Sales Quantity Market Share by Application (2018-2029)
Figure 43. Europe Autologous Biologics Sales Quantity Market Share by Country (2018-2029)
Figure 44. Europe Autologous Biologics Consumption Value Market Share by Country (2018-2029)
Figure 45. Germany Autologous Biologics Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. France Autologous Biologics Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. United Kingdom Autologous Biologics Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Russia Autologous Biologics Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Italy Autologous Biologics Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Asia-Pacific Autologous Biologics Sales Quantity Market Share by Type (2018-2029)
Figure 51. Asia-Pacific Autologous Biologics Sales Quantity Market Share by Application (2018-2029)
Figure 52. Asia-Pacific Autologous Biologics Sales Quantity Market Share by Region (2018-2029)
Figure 53. Asia-Pacific Autologous Biologics Consumption Value Market Share by Region (2018-2029)
Figure 54. China Autologous Biologics Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Japan Autologous Biologics Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Korea Autologous Biologics Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. India Autologous Biologics Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Southeast Asia Autologous Biologics Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Australia Autologous Biologics Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. South America Autologous Biologics Sales Quantity Market Share by Type (2018-2029)
Figure 61. South America Autologous Biologics Sales Quantity Market Share by Application (2018-2029)
Figure 62. South America Autologous Biologics Sales Quantity Market Share by Country (2018-2029)
Figure 63. South America Autologous Biologics Consumption Value Market Share by Country (2018-2029)
Figure 64. Brazil Autologous Biologics Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Argentina Autologous Biologics Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 66. Middle East & Africa Autologous Biologics Sales Quantity Market Share by Type (2018-2029)
Figure 67. Middle East & Africa Autologous Biologics Sales Quantity Market Share by Application (2018-2029)
Figure 68. Middle East & Africa Autologous Biologics Sales Quantity Market Share by Region (2018-2029)
Figure 69. Middle East & Africa Autologous Biologics Consumption Value Market Share by Region (2018-2029)
Figure 70. Turkey Autologous Biologics Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Egypt Autologous Biologics Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Saudi Arabia Autologous Biologics Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. South Africa Autologous Biologics Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Autologous Biologics Market Drivers
Figure 75. Autologous Biologics Market Restraints
Figure 76. Autologous Biologics Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Autologous Biologics in 2022
Figure 79. Manufacturing Process Analysis of Autologous Biologics
Figure 80. Autologous Biologics Industrial Chain
Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
